je.st
news
Tag: heart
Historic Chimney in Baku Will Be at the Heart of a New Shopping Complex Thanks to the Innovation of Newport Firm Cintec
2015-08-26 12:31:11| Industrial Newsroom - All News for Today
Cintec International is ensuring that a historic industrial chimney will be at the heart of The Twin Towers Port of Baku scheme. A demolition-threatened historic chimney in the Azerbaijan capital of Baku will now be the centre point of a multi-million pound new shopping complex thanks to the innovation of a...
5 times dogs stole our heart in luxury campaigns
2015-08-25 19:23:24| Footwear - Topix.net
They may be known as man's best friend, but if luxury brands have their way dogs are quickly becoming women's best friend. 2015 has definitely been the year of the dog when it comes to luxury brand campaigns, with more and more brands tapping into the trend and partnering up with adorable pooches to showcase their designs.
Diabetes drug shows 1st protection from heart complications
2015-08-21 00:52:29| Biotech - Topix.net
For the first time, there's evidence that a diabetes medication, Jardiance, reduces risk of the complications that are the top killer of diabetics: heart attacks, strokes and other cardiovascular damage. Preventing those is a long-elusive goal for the millions of diabetes patients and their doctors, and one analyst who's also a trained physician even called Thursday's news of a possible groundbreaking advance a "holy grail."
Tags: shows
heart
protection
1st
Abbott to Broaden Foundation in Structural Heart Therapies with Two Mitral Valve Transactions
2015-08-03 12:31:10| Industrial Newsroom - All News for Today
Acquisition of Tendyne Holdings, Inc. to Expand Abbott's Mitral Valve Therapies In Separate Transaction, Abbott Has Provided Capital and Secured an Option to Purchase Cephea Valve Technologies ABBOTT PARK, Ill. - Abbott (NYSE: ABT) announced today that it has entered into an agreement to purchase Tendyne...
Tags: heart
foundation
transactions
structural
New Heart Drugs Come With Expensive Price Tags
2015-07-27 15:18:03| Biotech - Topix.net
Two of the most anticipated new heart drugs to be launched in recent years have been priced well above analyst expectations, fueling the debate about whether modern medicines cost too much. Praluent, made by Sanofi and Regeneron Pharmaceuticals, and Entresto from Novartis are both treatments that represent significant advances for millions of patients at risk of serious heart problems.
Sites : [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] next »